Aquis Stock Exchange: Application for Admission Announcement

Aquis Stock Exchange Aquis Stock Exchange: Application for Admission Announcement 06-Jul-2023 / 07:00 GMT/BST The issuer is solely responsible for the content of this announcement. ANNOUNCEMENT OF APPLICATION FOR ADMISSION TO THE AQUIS GROWTH MARKET APPLICANT NAME: Blackpoint Biotech PLC APPLICANT REGISTERED OFFICE, PRINCIPLE PLACE OF BUSINESS (IF DIFFERENT) AND TELEPHONE NUMBER: 48-49 Chancery Lane, C/O Keystone Law, London, England, WC2A 1JF [phone] DIRECTORS AND PROPOSED DIRECTORS (IF APPLICABLE): Michael William Balfour, Non-Executive Chairman David Manuel Martinez, Chief Executive Officer Alexander James Robert Stormont Wakeford, Chief Financial Officer Dr Michael Barry Mayne, Chief Product Officer  APPLICANT SECTOR: Healthcare DESCRIPTION OF THE APPLICANT AND ITS ACTIVITIES: Blackpoint Biotech PLC is a medical cannabinoids company established to fulfil gaps in the medical cannabis market by creating products that provide fast onset of action and accurate dosing. NAME OF AQUIS CORPORATE ADVISER: First Sentinel Corporate Finance Limited NUMBER, CLASS AND PAR VALUE OF SECURITIES TO BE ADMITTED: 12,187,179 Ordinary Shares of £0.005 each SECURITIES IN PUBLIC HANDS AS A PERCENTAGE OF THE TOTAL NUMBER OF SECURITIES IN ISSUE (excluding securities held in treasury): 15.12% SHAREHOLDERS HOLDING MORE THAN FIVE PER CENT OF THE APPLICANT’S SHARE CAPITAL OR VOTING RIGHTS PRE- AND POST-ADMISSION: Shareholder Shares Pre-admission % Pre-admission Shares Post-admission % Post-admission David Martinez 4,078,102 33.46% 4,078,102 33.46% Alexander Wakeford 1,581,696 12.98% 1,581,696 12.98% Michael Mayne 2,105,000 17.27% 2,105,000 17.27% Creedy Carver Chickens Limited 2,271,410 18.64% 2,271,410 18.64% TIMETABLE FOR ANY OFFER OF TRANSFERABLE SECURITIES TO THE PUBLIC: N/A THE EXPECTED ADMISSION DATE: 20 July 2023 WEBSITE ADDRESS WHERE INVESTOR INFORMATION WILL BE AVAILABLE FOR INSPECTION: www.blackpointbiotech.com In respect of an update to a prior application announcement, the date of the original announcement should also be disclosed as follows: UPDATE TO A PRIOR APPLICATION ANNOUNCEMENT RELEASED ON: N/A Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

End of Announcement - EQS News Service

1673521  06-Jul-2023